BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1001 related articles for article (PubMed ID: 26531830)

  • 1. Clinical value of regression of electrocardiographic left ventricular hypertrophy after aortic valve replacement.
    Yamabe S; Dohi Y; Higashi A; Kinoshita H; Sada Y; Hidaka T; Kurisu S; Shiode N; Kihara Y;
    Heart Vessels; 2016 Sep; 31(9):1497-503. PubMed ID: 26531830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maladaptive remodeling is associated with impaired survival in women but not in men after aortic valve replacement.
    Petrov G; Dworatzek E; Schulze TM; Dandel M; Kararigas G; Mahmoodzadeh S; Knosalla C; Hetzer R; Regitz-Zagrosek V
    JACC Cardiovasc Imaging; 2014 Nov; 7(11):1073-80. PubMed ID: 25306541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between electrocardiographic left ventricular hypertrophy criteria and echocardiographic mass in patients undergoing transcatheter aortic valve replacement.
    Sjöberg S; Sundh F; Schlegel T; Maynard C; Rück A; Wagner G; Ugander M
    J Electrocardiol; 2015; 48(4):630-6. PubMed ID: 25865909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal strain predicts left ventricular mass regression after aortic valve replacement for severe aortic stenosis and preserved left ventricular function.
    Gelsomino S; Lucà F; Parise O; Lorusso R; Rao CM; Vizzardi E; Gensini GF; Maessen JG
    Heart Vessels; 2013 Nov; 28(6):775-84. PubMed ID: 23180240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender differences in factors influencing electrocardiographic findings of left ventricular hypertrophy in severe aortic stenosis.
    Satoh S; Omura S; Inoue H; Ejima E; Shimozono K; Hayashi M; Mori T; Takenaka K; Kawamura N; Numaguchi K; Mori E; Asoh A; Nakamura T; Hiyamuta K
    Heart Vessels; 2014 Sep; 29(5):659-66. PubMed ID: 23979264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Diastolic Strain Rate in Relation to Systolic and Diastolic Function and Prognosis in Aortic Stenosis.
    Dahl JS; Barros-Gomes S; Videbæk L; Poulsen MK; Issa IF; Carter-Storch R; Christensen NL; Kumme A; Pellikka PA; Møller JE
    JACC Cardiovasc Imaging; 2016 May; 9(5):519-28. PubMed ID: 27085434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left Ventricular Hypertrophy Does Not Affect 1-Year Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Varshney AS; Manandhar P; Vemulapalli S; Kirtane AJ; Mathew V; Shah B; Lowenstern A; Kosinski AS; Kaneko T; Thourani VH; Bhatt DL
    JACC Cardiovasc Interv; 2019 Feb; 12(4):373-382. PubMed ID: 30784643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of ECG criteria for left ventricular hypertrophy before and after aortic valve replacement using magnetic resonance imaging.
    Beyerbacht HP; Bax JJ; Lamb HJ; van der Laarse A; Vliegen HW; de Roos A; Zwinderman AH; van der Wall EE
    J Cardiovasc Magn Reson; 2003 Jul; 5(3):465-74. PubMed ID: 12882077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular hypertrophy and left atrial dilatation persist and are associated with reduced survival after valve replacement for aortic stenosis.
    Beach JM; Mihaljevic T; Rajeswaran J; Marwick T; Edwards ST; Nowicki ER; Thomas J; Svensson LG; Griffin B; Gillinov AM; Blackstone EH
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):362-369.e8. PubMed ID: 23312984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Prediction in Aortic Valve Replacement: Incremental Value of the Preoperative Echocardiogram.
    Tan TC; Flynn AW; Chen-Tournoux A; Rudski LG; Mehrotra P; Nunes MC; Rincon LM; Shahian DM; Picard MH; Afilalo J
    J Am Heart Assoc; 2015 Oct; 4(10):e002129. PubMed ID: 26504147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of electrocardiographic left ventricular hypertrophy following transcatheter aortic valve replacement.
    Tanaka T; Yahagi K; Asami M; Ninomiya K; Kikushima H; Okuno T; Horiuchi Y; Yuzawa H; Komiyama K; Tanaka J; Yokozuka M; Miura S; Aoki J; Tanabe K
    J Cardiol; 2021 Apr; 77(4):346-352. PubMed ID: 33455846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of Electrocardiographic Left Ventricular Hypertrophy After Transcatheter Aortic Valve Implantation: Insights from the OCEAN-TAVI Registry.
    Koga M; Izumo M; Yoneyama K; Akashi YJ; Yashima F; Tada N; Yamawaki M; Shirai S; Naganuma T; Yamanaka F; Ueno H; Tabata M; Mizutani K; Takagi K; Watanabe Y; Yamamoto M; Hayashida K;
    Am J Cardiol; 2023 Oct; 204():130-139. PubMed ID: 37541149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of postoperative medical treatment on left ventricular mass regression after aortic valve replacement.
    Helder MR; Ugur M; Bavaria JE; Kshettry VR; Groh MA; Petracek MR; Jones KW; Suri RM; Schaff HV
    J Thorac Cardiovasc Surg; 2015 Mar; 149(3):781-6. PubMed ID: 25433642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
    Greve AM; Boman K; Gohlke-Baerwolf C; Kesäniemi YA; Nienaber C; Ray S; Egstrup K; Rossebø AB; Devereux RB; Køber L; Willenheimer R; Wachtell K
    Circulation; 2012 Jan; 125(2):346-53. PubMed ID: 22147903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left Ventricular Hypertrophy and Clinical Outcomes Over 5 Years After TAVR: An Analysis of the PARTNER Trials and Registries.
    Gonzales H; Douglas PS; Pibarot P; Hahn RT; Khalique OK; Jaber WA; Cremer P; Weissman NJ; Asch FM; Zhang Y; Gertz ZM; Elmariah S; Clavel MA; Thourani VH; Daubert M; Alu MC; Leon MB; Lindman BR
    JACC Cardiovasc Interv; 2020 Jun; 13(11):1329-1339. PubMed ID: 32499024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CarboMedics supra-annular Top Hat valve improves long-term left ventricular mass regression.
    Mosquera VX; Bouzas-Mosquera A; Bautista-Hernandez V; Estévez-Cid F; Herrera-Noreña JM; Alvarez-García N; Cuenca-Castillo JJ
    J Thorac Cardiovasc Surg; 2014 Dec; 148(6):2845-53.e1. PubMed ID: 25131169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of electrocardiographic left ventricular hypertrophy is associated with increased mortality after transcatheter aortic valve replacement.
    Kampaktsis PN; Ullal AV; Swaminathan RV; Minutello RM; Kim L; Bergman GS; Feldman DN; Singh H; Wong SC; Okin PM
    Clin Cardiol; 2018 Sep; 41(9):1246-1251. PubMed ID: 30062778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-year hemodynamic performance, left ventricular mass regression, and prosthetic-patient mismatch after rapid deployment aortic valve replacement in 287 patients.
    Haverich A; Wahlers TC; Borger MA; Shrestha M; Kocher AA; Walther T; Roth M; Misfeld M; Mohr FW; Kempfert J; Dohmen PM; Schmitz C; Rahmanian P; Wiedemann D; Duhay FG; Laufer G
    J Thorac Cardiovasc Surg; 2014 Dec; 148(6):2854-60. PubMed ID: 25218544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Speckle tracking echocardiography derived 2-dimensional myocardial strain predicts left ventricular function and mass regression in aortic stenosis patients undergoing aortic valve replacement.
    Staron A; Bansal M; Kalakoti P; Nakabo A; Gasior Z; Pysz P; Wita K; Jasinski M; Sengupta PP
    Int J Cardiovasc Imaging; 2013 Apr; 29(4):797-808. PubMed ID: 23197274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of aortic prosthesis-patient mismatch on left ventricular mass regression.
    Alassal MA; Ibrahim BM; Elsadeck N
    Asian Cardiovasc Thorac Ann; 2014 Jun; 22(5):546-50. PubMed ID: 24867028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.